Universitaetsklinikum Muenster AöR

6 trials 1 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

1 Recruiting

5 Completed trials

14 Countries active

27 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase I

Phase III: 2 Phase II: 2 Phase IV: 1 Phase I: 1

100%

5 of 5 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Diffuse large B-cell lymphoma 1 Glioblastoma 1

Top IMPs

BEVACIZUMAB 1 COPANLISIB DIHYDROCHLORIDE 1 IPILIMUMAB 1 NIVOLUMAB 1 TACROLIMUS 1

All trials

6 total

LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Phase III 14 countries
A clinical study to determine the dose and assess safety and efficacy of radioimmuntherapy in patients with glioblastoma, where Lutetium 177… Ended

2024-513638-39-00 Phase I 1 country
Breaking the big Five Barriers of Brain Metastasis: A prospective phase II, open-label, multi-center trial of combined nivolumab, ipilimumab… Ended

2024-512684-31-00 Phase II 1 country BEVACIZUMAB; IPILIMUMAB; NIVOLUMAB
Multicentre, open-label, randomised, two-arm, parallel-group, superiority study to assess bioavailability and practicability of Envarsus® co… Ended

2024-518033-28-00 Phase IV 1 country TACROLIMUS
B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and… Ended

2023-505509-18-00 Phase III 7 countries
A prospective multicenter phase 2 study of copanlisib in combination with rituximab and CHOP chemotherapy (COPA-R-CHOP) in patients with pre… Ended

2024-517166-42-00 Phase II 1 country COPANLISIB DIHYDROCHLORIDE

Showing 1–6 of 6 trials

← All sponsors A–Z